-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized therapy for urothelial cancer: review of the clinical evidence
Elizabeth A Guancial, Dipanjan Chowdhury,Jonathan E Rosenberg
Review Article: Clinical Investigation
-
Personalized therapy for urothelial cancer: review of the clinical evidence
Elizabeth A Guancial, Dipanjan Chowdhury,Jonathan E Rosenberg
Review Article: Clinical Investigation
-
Personalized therapy for urothelial cancer: review of the clinical evidence
Elizabeth A Guancial, Dipanjan Chowdhury,Jonathan E Rosenberg
Review Article: Clinical Investigation
-
Personalized therapy for urothelial cancer: review of the clinical evidence
Elizabeth A Guancial, Dipanjan Chowdhury,Jonathan E Rosenberg
Review Article: Clinical Investigation
-
Personalized therapy for urothelial cancer: review of the clinical evidence
Elizabeth A Guancial, Dipanjan Chowdhury,Jonathan E Rosenberg
Review Article: Clinical Investigation
-
Personalized therapy for urothelial cancer: review of the clinical evidence
Elizabeth A Guancial, Dipanjan Chowdhury,Jonathan E Rosenberg
Review Article: Clinical Investigation
-
Personalized therapy for urothelial cancer: review of the clinical evidence
Elizabeth A Guancial, Dipanjan Chowdhury,Jonathan E Rosenberg
Review Article: Clinical Investigation
-
Personalized therapy for urothelial cancer: review of the clinical evidence
Elizabeth A Guancial, Dipanjan Chowdhury,Jonathan E Rosenberg
Review Article: Clinical Investigation